Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery-Reference-Cited by-同舟云学术

Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery

Published:2003-11 Issue:1 Volume:93 Page:15-28
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Bhavane Rohan,Karathanasis Efstathios,Annapragada Ananth V

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. T. Mckone, B. Huey, E. Downing, L. Duffy, Strategies to protect the health of deployed U.S. forces: detecting, characterizing, and documenting exposures, in: Division of Military Science and Technology and Board on Environmental Studies and Toxicology, National Research Council (Ed.), 2000.

2. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularenis infection in mice;Conley;Antimicrobial Agents and Chemotherapy,1997

3. Inhalation Delivery of Therapeutic Peptides and Proteins;Adjei,1997

4. Large porous particles for pulmonary drug delivery;Edwards;Science,1997

5. Hollow porous particles in metered dose inhalers;Dellamary;Pharmaceutical Research,2000

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics;Advances in Colloid and Interface Science;2023-05

2. Development and application of ribonucleic acid therapy strategies against COVID-19;International Journal of Biological Sciences;2022

3. Current strategies and future perspectives in COVID-19 therapy;Stem Cells and COVID-19;2022

4. Dry Powder for Pulmonary Delivery: A Comprehensive Review;Pharmaceutics;2020-12-28

5. Prospects for RNAi Therapy of COVID-19;Frontiers in Bioengineering and Biotechnology;2020-07-30